April 29, 2021
RegMed Investors’ (RMi) closing bell: the trend was definitely not our friend today as the upside trail got cold
April 28, 2021
RegMed Investors’ (RMi) closing bell: I thought up-downs were an exercise
April 27, 2021
RegMed Investors’ (RMi) closing bell: cell and gene therapy sector swings low again
April 23, 2021
RegMed Investors’ (RMi) closing bell: an answer to this a.m.’s question, “what will be sustainable”?
April 22, 2021
RegMed Investors’ (RMi) closing bell: a volatile market session with the cell and gene therapy sector maintaining altitude
April 21, 2021
RegMed Investors’ (RMi) closing bell: the come-backs, a far-cry from yesterday’s sector advance/decline (A/D) line
April 20, 2021
RegMed Investors’ (RMi) closing bell: another sell-off and downer for the sector
April 19, 2021
RegMed Investors’ (RMi) closing bell: cell and gene therapy sector suffers from arrested development
April 15, 2021
RegMed Investors’ (RMi) closing bell: sector climbs again
April 14, 2021
RegMed Investors’ (RMi) closing bell: “the sure way of gambling is getting something for nothing” after a Tuesday bounce
April 13, 2021
RegMed Investors’ (RMi) closing bell: the gain and the pain with a spike, a flame -up and a shake-off after JNJ vaccine halted
April 12, 2021
RegMed Investors’ (RMi) closing bell: it was scary, staring at the cell and gene therapy sector abyss
April 9, 2021
RegMed Investors’ (RMi) closing bell: just another sector beat-down
April 8, 2021
RegMed Investors’ (RMi) closing bell: backup today, reversing yesterday’s algorithmic curse
April 7, 2021
RegMed Investors’ (RMi) closing bell: barely any distance in the upside
April 6, 2021
RegMed Investors’ (RMi) closing bell: what’s being shaken in today’s sector?
April 5, 2021
RegMed Investors’ (RMi) closing bell: sector didn’t trend far from Thursday’s highs
April 5, 2021
RegMed Investors’ (RMi) closing bell: sector didn’t trend far from Thursday’s highs
April 5, 2021
RegMed Investors’ (RMi) closing bell: sector didn’t trend far from Thursday’s highs
April 1, 2021
RegMed Investors’ (RMi) closing bell: Q2’s much anticipated word, expectation
March 31, 2021
RegMed Investors’ (RMi) closing bell: the month is over as the sector closes out March and the Q1 on a high note
March 30, 2021
RegMed Investors’ (RMi) closing bell: market dumps, sector jumps
March 29, 2021
RegMed Investors’ (RMi) closing bell: flipping the bird to risk
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2025 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.